Group Leader
Marco Herling, MD

Natali Pflug, MD
Till Braun, MD

New perspective on future targeted therapy approaches published.
Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood
New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.
New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports